Onslow Memorial Hospital issued the following announcement on Aug. 19.
Onslow Radiation Oncology, a division of Onslow Memorial Hospital, is pleased to announce the availability of Optune Lua for the treatment of malignant pleural mesothelioma (MPM). Experts at Onslow Radiation Oncology are now certified to prescribe this wearable and portable medical device, the first FDA-approved MPM treatment in more than 15 years.
Original source can be found here.
Source: Onslow Memorial Hospital
Alerts Sign-up